Based on recent data, Protara Therapeutics, Inc. (TARA) shows an Average True Range (ATR) of 0.57 and an Enterprise Value of -1.88M. Its average trading volume over the past 3 months is 670.91K, indicating liquidity. These fundamental metrics provide insight into TARA's underlying financial health and market activity.
| ATR | 0.57 |
| Enterprise Value | -1.88M |
| Avg Vol (3 Months) | 670.91K |
| Avg Vol (10 Days) | 340.76K |
Protara Therapeutics, Inc. (TARA) technical indicators as of August 6, 2026: the SMA 20 is -12.58%, SMA 50 at -3.56%, and SMA 200 at 27.5%. The RSI 14 value is 43.31, suggesting its current momentum. These technical analysis signals help assess TARA's price trends and potential future movements.
| SMA 20 | -12.58% |
| SMA 50 | -3.56% |
| SMA 200 | 27.5% |
| RSI 14 | 43.31 |
Protara Therapeutics, Inc. (TARA) stock performance overview as of August 6, 2026: The 52-week high is $7.82 (currently -26.21% below), and the 52-week low is $2.97 (currently 108.3% above). Over the past year, TARA's performance is 20.95%, compared to the S&P 500's 4.09% change.
| 52-Week High | 7.82 |
| 52-Week High Chg | -26.21% |
| 52-Week Low | 2.97 |
| 52-Week Low Chg | +108.30% |
| S&P 500 52-Week Chg | 4.09% |
According to market data, Protara Therapeutics, Inc. (TARA) stock's recent performance metrics show that over the last month, TARA is 4.67%, with a Year-to-Date (YTD) performance of 5.07%. Over the past year, the stock has seen a 20.95% change. These figures summarize TARA's price movements across various periods, reflecting its historical returns.
| Period | 1 Week | 1 Month | Quarter | Half Year | 1 Year | YTD |
|---|---|---|---|---|---|---|
| High | 4.13 | 4.37 | 5.69 | 7.5 | 7.82 | 7.5 |
| Low | 3.81 | 3.77 | 3.62 | 3.62 | 2.97 | 3.62 |
| Performance | +6.87% | +4.67% | +2.00% | +63.74% | +20.95% | +5.07% |
According to current financial data, TARA stock's P/E (TTM) ratio is -2.78, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.24. Key valuation ratios for TARA, including P/S (N/A), P/B (0.96), and P/FCF (-3.62), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.
| Valuation | TARA | Sector Median | Industry Avg | S&P 500 |
|---|---|---|---|---|
| P/E (TTM) | -2.78 | -1.24 | -193.07 | 32.59 |
| P/S (TTM) | N/A | 3.71 | 464.88 | 5.98 |
| P/B (TTM) | 0.96 | 0.58 | -3445.17 | 5.6 |
| P/FCF (TTM) | -3.62 | -2.01 | -645.86 | 31.69 |
© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep